Why Speed Matters in Allogeneic Cell Therapy Fill & FinishAnd how faster filling protects product quality, reduces risk, and improves scalabilityAs allogeneic (“off the shelf”) cell therapies continue to expand, manufacturing teams face a clear challenge: produce...

As tissue banking continues to scale, precision and consistency are becoming just as critical as compliance. Whether processing dermis, amnion, or other soft tissues, banks are being asked to deliver uniform grafts while operating under tighter cleanroom controls and...

Cell and gene therapy developers continually encounter significant hurdles during the fill & finish phase—challenges best illustrated by manual workflows that are prone to variability, risk of contamination, and limited scalability. This whitepaper, authored by...

In recent years, a remarkable revolution in cancer treatment has taken center stage, captivating the medical community and offering hope to millions of patients and their families. Chimeric Antigen Receptor T-cell therapy, commonly known as CAR-T therapy, has emerged...

Demineralization and decellularization are two critical processes that have become indispensable in the field of regenerative medicine. Both techniques are pivotal in the development of advanced biomaterials and tissue engineering strategies. Demineralization and...

BreakThru Strategies, a visionary parent company, has orchestrated a groundbreaking collaboration between two pioneering entities in the biomedical landscape - Ardent Animal Health and Xiogenix. The fusion of Ardent Animal Health's expertise in animal stem cell...